Achieving blood pressure goals study in uncontrolled hypertensive patients treated with a fixed-dose combination of ramipril/hydrochlorothiazide: The ASTRAL study

Cardiovascular Journal of Africa

Volumn 22, Issue 2, 2011, Pages 79-84

  Okpechi, I G ^a   Schoeman, H S ^b   Longo Mbenza, B ^c,d   Oke, D A ^e   Kingue, S ^f   Nkoua, J L ^g   Rayner, B L ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Clinstat   (South Africa)

^c WALTER SISULU UNIVERSITY   (South Africa)

^d University of Kinshasa Hospital   (Congo)

^e LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^f UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^g University Hospital of Brazzaville   (Congo)

Author keywords

ACE inhibitors; Black Africans; Hypertension; Ramipril; Thiazides

Indexed keywords

HYDROCHLOROTHIAZIDE PLUS RAMIPRIL;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; COMORBIDITY; COUGHING; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EPISTAXIS; FACE EDEMA; FEMALE; GOUT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; OBESITY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URINE RETENTION;

EID: 79955799822     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2010-086     Document Type: Article

References (24)

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223. (Pubitemid 40138015)
2. Asmar R, Vol S, Pannier B, et al. High blood pressure and associated cardiovascular risk factors in France. J Hypertens 2001; 19: 1727-1732. (Pubitemid 32924937)
3. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. (Pubitemid 46924065)
4. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. J Am Med Assoc 2003; 289: 2363-2369. (Pubitemid 37430168)
5. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-19. (Pubitemid 38293521)
6. Marques-Vidal P, Arveiler D, Amouyel P, et al. Sex differences in awareness and control of hypertension in France. J Hypertens 1997; 15: 1205-1210. (Pubitemid 27453171)
7. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
8. De Henauw S, De Bacquer D, Fonteyne W, et al. Trends in the prevalence, detection, treatment and control of arterial hypertension in the Belgian adult population. J Hypertens 1998; 16: 277-284. (Pubitemid 28101755)
9. Psaltopoulou T, Orfanos P, Naska A, et al. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 2004; 33: 1345-1352. (Pubitemid 40124939)
10. Addo J, Smeeth L, Leon DA. Hypertension in sub-Saharan Africa. Hypertension 2007; 50: 1-7.
11. Chobanian AV, Bakris GL, Black HR, et al. and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
12. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913. (Pubitemid 35472129)
13. WHO. Obesity: Preventing and managing the Global Epidemic - Report of a WHO Consultation on Obesity, 3-5 June 1997, Geneva (Last assessed on 3 March 2010). http://www.who.int/nutrition/publications/obesity-executive-summary.pdf
14. Opie LH, Mayosi BM. Cardiovascular disease in sub-Saharan Africa. Circulation 2005; 112: 3536-3540. (Pubitemid 43739528)
15. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001; 344:1351-1357. (Pubitemid 32378389)
16. Rahman M, Douglas JG, Wright JT. Pathophysiology and treatment implications of hypertension in the African-American population. Endocrinol Metab Clin North Am 1997; 26: 125-144. (Pubitemid 27123898)
17. Sareli P, Radevski IV, Valtchanova ZP, et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects. Results of a randomized trial in Johannesburg, South Africa. Arch Intern Med 2001; 161: 965-971.
18. Wright JT, Jr, Bakris G; Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease results from the AASK trial. J Am Med Assoc 2002; 288: 2421-2431. (Pubitemid 35340538)
19. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation study investigators. N Engl J Med 2000; 342: 145-153.
20. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-828.
21. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005; 165: 1637-1642. (Pubitemid 41124159)
22. Cupido C, Rayner B. Life-threatening angio-oedema and death associated with the ACE inhibitor Enalapril. S Afr Med J 2007; 97: 244-245. (Pubitemid 46614298)
23. Seedat YK, Croasdale MA, Milne FJ, et al. Guideline committee, Southern African Hypertension Society. South African hypertension guideline 2006. S Afr Med J 2006; 96: 337-362
24. ALLHAT collaborative research group. Diuretic versus α-blocker as first-step antihypertensive therapy. Final results from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42: 239-246.